Medicine
CRISPR-Based Biosensors for Rapid Pathogen Detection
Quick fact
CRISPR-based diagnostic tests like SHERLOCK can detect as few as one molecule of a pathogen's genetic material and can be read on paper strips, much like a pregnancy test.
Why this is interesting
You've probably heard of CRISPR as a gene-editing tool, but did you know it can also be used as a rapid disease detector, finding a virus in a drop of blood within minutes? How does a system designed to cut DNA become a biosensor?
Read the full explanation
Understanding CRISPR-Based Biosensors for Rapid Pathogen Detection
Imagine CRISPR as a molecular watchdog that patrols our cells, carrying a photo of a specific intruder (guide RNA) and a pair of scissors (Cas enzyme). In its natural role, it snips the intruder's DNA. In diagnostics, we use this same watchdog to detect a pathogen. We first amplify any tiny amount of pathogen's genetic material in the sample (using isothermal amplification at constant temperature). Then, we present that material to the CRISPR complex. If the pathogen is present, the guide RNA binds to its matching target sequence. This binding activates the Cas scissors, which now not only cuts that target but also goes into a frenzy, cutting any nearby RNA or DNA indiscriminately—a process called collateral cleavage. We include synthetic RNA probes that are labeled with a fluorescent marker. When they are cut, the marker becomes visible, indicating the presence of the pathogen. The entire process can be performed in a simple tube and read with a smartphone or a lateral flow strip.
A deeper explanation
The principle is based on RNA-guided nuclease activity. The Cas enzyme (typically Cas12a or Cas13a) is programmed with a guide RNA complementary to the pathogen's sequence. When the guide RNA finds its target, a conformational change activates the enzyme's non-specific nuclease activity, leading to collateral cleavage. The signal is generated by the cleavage of reporter molecules. Specificity comes from the guide RNA's sequence; it can discriminate between even single nucleotide differences. The system works at a constant temperature (37°C) using isothermal amplification like RPA, eliminating the need for thermal cyclers which are required in PCR. This makes CRISPR biosensors highly portable and affordable, suitable for low-resource settings. Applications include detecting viruses like SARS-CoV-2, Zika, dengue, and bacteria like tuberculosis. They can also distinguish between closely related strains. The quick turn-around time (less than an hour from sample to result) allows for rapid containment during outbreaks. This technology bridges the gap between lab-based testing and at-home diagnostics, potentially revolutionizing how we manage infectious diseases.